T2 corrected quantification method of l-p-boronophenylalanine using proton magnetic resonance spectroscopy for boron neutron capture therapy

Applied Radiation and Isotopes

Volumn 67, Issue 7-8 SUPPL., 2009, Pages

  Yamamoto, Yohei ^a   Isobe, Tomonori ^b   Yamamoto, Tetsuya ^a   Shibata, Yasushi ^a   Anno, Izumi ^c   Nakai, Kei ^a   Shirakawa, Makoto ^a   Matsushita, Akira ^a   Sato, Eisuke ^d   Matsumura, Akira ^a  

^a University of Tsukuba   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c IBARAKI PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

^d KITASATO UNIVERSITY   (Japan)

Author keywords

l p boronophenylalanine (BPA); Magnetic resonance spectroscopy (MRS); Quantification method; T2 correction

Indexed keywords

ASPARTIC ACIDS; BORON NEUTRON CAPTURE THERAPY; CONCENTRATION OF; CORRELATION COEFFICIENT; IN-VIVO; L-P-BORONOPHENYLALANINE (BPA); NON-INVASIVE; PROTON MAGNETIC RESONANCE SPECTROSCOPIES; PROTON MRS; QUANTIFICATION METHOD; QUANTIFICATION METHODS; SIGNAL INTENSITIES; T2 CORRECTION; WATER SIGNALS;

BORON; BORON COMPOUNDS; CHROMIUM; CONCENTRATION (PROCESS); NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ORGANIC ACIDS; PARTICLE DETECTORS; PROTONS; RELAXATION PROCESSES; SPECTRUM ANALYSIS;

RESONANCE;

4 BORONOPHENYLALANINE; CHOLINE; CREATININE; N ACETYLASPARTIC ACID; WATER;

ACCURACY; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; NEUTRON CAPTURE THERAPY; NON INVASIVE MEASUREMENT; PHANTOM; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; RELAXATION TIME; SIGNAL DETECTION;

BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; HUMANS; ISOTOPES; MAGNETIC RESONANCE SPECTROSCOPY; PHANTOMS, IMAGING; PHENYLALANINE; PROTONS; RADIATION-SENSITIZING AGENTS;

EID: 67649389415     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2009.03.060     Document Type: Article

References (10)

1. Barth RF., Coderre JA., Vicente MG., and Blue TE. Boron neutron capture therapy of cancer: current status and future prospects. Clin. Cancer Res. 11 (2005) 3987-4002
2. Bendel P., Margalit R., and Salomon Y. Optimized 1H MRS and MRSI methods for the in vivo detection of boronophenylalanine. Magn. Reson. Med. 53 (2005) 1166-1171
3. Gottschalk M., Lamalle L., and Segebarth C. Short-TE localised 1H MRS of the human brain at 3 T: quantification of the metabolite signals using two approaches to account for macromolecular signal contributions. NMR Biomed. 21 (2008) 507-517
4. Heikkinen S., Kangasmäki A., Timonen M., Kankaanranta L., Häkkinen A.M., Lundbom N., Vähätalo J., and Savolainen S. 1H MRS of a boron neutron capture therapy 10B-carrier, l-p-boronophenylalanine-fructose complex, BPA: phantom studies at 1.5 and 3.0 T. Phys. Med. Biol. 48 (2003) 1027-1039
5. Isobe T., Matsumura A., Anno I., Yoshizawa T., Nagatomo Y., Itai Y., and Nose T. Quantification of cerebral metabolites in glioma patients with proton MR spectroscopy using T2 relaxation time correction. Magn. Reson. Imaging 20 (2002) 343-349
6. Nichols T.L., Kabalka G.W., Miller L.F., Khan M.K., and Smith G.T. Improved treatment planning for boron neutron capture therapy for glioblastome multiforme using fluoline-18 labeled boronophenylalanine and positron emission tomography. Med. Phys. 29 (2002) 2351-2358
7. Provencher S.W. Automatic quantitation of localized in vivo 1H spectra with LC Model. NMR Biomed. 14 4 (2001) 260-264
8. Schick F., Nägela T., Klose U., and Lutz O. Lactate quantification by means of press spectroscopy-influence of refocusing pulses and timing scheme. Magn. Reson. Imaging 13 (1995) 309-319
9. Yamamoto T., Nakai K., and Matsumura A. Boron neutron capture therapy for glioblastoma. Cancer Lett. 262 2 (2008) 143-152
10. Zuo C.S., Prasad P.V., Busse P., Tang L., and Zamenhof R.G. Proton nuclear magnetic resonance measurement of p-boronophenylalanine (BPA): a therapeutic agent for boron neutron capture therapy. Med. Phys. 26 7 (1999) 1230-1236